Beranda › Tekanan Darah Tinggi › Minnesota
Uji klinis Tekanan Darah Tinggi di Minnesota
16 studi untuk Tekanan Darah Tinggi mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Minneapolis Heart Institute, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06059638Obstructive Sleep Apnea Among Somali-Americans
- Mayo Clinic, Rochester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04124848A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Headlands Research-Twin Cities, Maplewood
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Richfield
- Clinical Trial Site, Saint Cloud
- Clinical Trial Site, Saint Paul
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07181109Study of Disrupted Sleep in Somali Americans
- Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05411029A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06150560Sleep Restriction and Parental History of Hypertension
- Mayo Clinic in Rochester, Rochester
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 35 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06482814Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial
- Mayo Clinic in Rochester, Rochester
Menerima peserta
Usia 40 hingga 55 · Wanita · Diperbarui 13 Agu 2026 · NCT06826755Global Paradise System US Post Approval Study
- Metropolitan Heart & Vascular Institute, Coon Rapids
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06297291Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- CentraCare - St. Cloud Hospital, Saint Cloud
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06402968HTN App for HTN Control and Cardiovascular Health Among African-Americans
- Mayo Clinic, Rochester
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06346886Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy
- Mayo Clinic, Rochester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06886087HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
- University of Minnesota, Minneapolis
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 14 Jan 2026 · NCT07204756Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
- University of Minnesota, Minneapolis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 35 hingga 70 · Wanita · Diperbarui 8 Jan 2026 · NCT04439370Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
- Mayo Clinic-Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 16 Des 2025 · NCT06039176Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
- University of Minnesota, Minneapolis
Menerima pesertaFase awal 1
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 3 Okt 2025 · NCT06507657Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.